Adenosine deaminase activity in patients with carcinoma of the bladder.
Adenosine deaminase is an important enzyme in purine metabolism, and patients with abnormal lymphocyte and erythrocyte adenosine deaminase levels have been shown to have impaired immune competence. Since immune factors have been shown to be important in patients with transitional cell carcinoma of the bladder we studied adenosine deaminase activity in the hemic cells of 48 patients with this tumor. Lymphocyte adenosine deaminase levels were elevated in patients with transitional cell carcinoma and correlated with stage, activity, clinical course and tumor resection but not with tumor grade. Erythrocyte adenosine deaminase levels also were elevated in patients with transitional cell carcinoma but did not correlate with other disease parameters. Lymphocyte adenosine deaminase activity in patients with transitional cell carcinoma may be a sensitive indicator of disease activity and further studies may provide insight into the host-tumor relationship at the enzyme level.
D000243:Adenosine Deaminase / Q000378:metabolism*; D000917:Antibody Formation; D002295:Carcinoma, Transitional Cell / Q000201:enzymology* / Q000473:pathology / Q000601:surgery; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D009700:Nucleoside Deaminases / Q000378:metabolism*; D001749:Urinary Bladder Neoplasms / Q000201:enzymology* / Q000473:pathology / Q000601:surgery
D009700:Nucleoside Deaminases; D000243:Adenosine Deaminase